Should You Buy Werewolf Therapeutics Inc (HOWL) Stock Monday Morning?

Werewolf Therapeutics Inc (HOWL) has risen Monday morning, with the stock climbing 3.66% in pre-market trading to 2.55. HOWL's short-term technical score of 62 indicates that the stock has traded more bullishly over the last month than 62% of stocks on the market. In the Biotechnology industry, which ranks 134 out of 146 industries, the stock ranks higher than 79% of stocks. Werewolf Therapeutics Inc has risen 14.95% over the past month, closing at $2.05 on October 2. During this period of time, the stock fell as low as $1.78 and as high as $2.65. HOWL has an average analyst recommendation of Strong Buy. The company has an average price target of $11.55.

HOWL has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on HOWL!

See Full HOWL Report

Werewolf Therapeutics Inc has a Long-Term Technical rank of 70. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 30% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, HOWL ranks better than 132% of stocks.

Important Dates for Investors in HOWL:

-Werewolf Therapeutics Inc is set to release earnings on 2023-11-09. Over the last 12 months, the company has reported EPS of $-1.25. -We do not have a set dividend date for Werewolf Therapeutics Inc at this time. Click Here To Get The Full Report on Werewolf Therapeutics Inc (HOWL)